C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 209/86 (2006.01) A61K 31/40 (2006.01) A61P 25/28 (2006.01) A61P 29/00 (2006.01) A61P 31/10 (2006.01) C07D 209/88 (2006.01) C07D 401/12 (2006.01) C07D 403/06 (2006.01) C07D 411/06 (2006.01) C07D 411/14 (2006.01) C07D 471/04 (2006.01)
Patent
CA 2560700
The present invention relates to compounds of the formula (I) wherein R1, R2, R3, R4, R5, X1, X2, X3, X4, n, and k are defined in the description and claims, and pharmaceutically acceptable salts and/or pharmaceutically acceptable esters thereof. The compounds are useful for in the treatment and prophylaxis of diseases which are modulated by LXR.alpha. and/or LXR.szlig. agonists, including increased lipid and cholesterol levels, particularly low HDL-cholesterol, high LDL-cholesterol, atherosclerotic diseases, diabetes, particularly non-insulin dependent diabetes mellitus, metabolic syndrome, dyslipidemia, Alzheimer's disease, sepsis, inflammatory diseases such as colitis, pancreatitis, cholestasis/fibrosis of the liver, and diseases that have an inflammatory component such as Alzheimer's disease or impaired/improvable cognitive function.
La présente invention concerne des composés de la formule (I) dans laquelle R?1¿, R?2¿, R?3¿, R?4¿, R?5¿, X?1¿, X?2¿, X?3¿, X?4¿, n et k ont la notation figurant dans la description et dans les revendications, ainsi que leurs sels pharmaceutiquement acceptables et/ou leurs esters pharmaceutiquement acceptables. Les composés sont utiles dans le traitement et dans la prophylaxie de maladies lesquelles sont modulées par des agonistes de LXR.alpha. et/ou LXR.beta., notamment des niveaux accrus de lipide et de cholestérol, en particulier du cholestérol HDL réduit, du cholestérol HDL élevé, des maladies athéroscléreuses, le diabète, notamment le diabète non-insulino dépendant, le syndrome métabolique, la dyslipidémie, la maladie d'Alzheimer, la sepsie, les maladies inflammatoires telles que la colite, la pancréatite, la cholestase/la fibrose du foie ainsi que des maladies présentant une composante inflammatoire telle que la maladie d'Alzheimer ou une fonction cognitive déficiente/susceptible d'amélioration.
Dehmlow Henrietta
Kuhn Bernd
Masciadri Raffaello
Panday Narendra
Ratni Hasane
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Tetrahydrocarbazoles and derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydrocarbazoles and derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydrocarbazoles and derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1442609